Minireview: The impact of antenatal therapeutic synthetic glucocorticoids on the developing fetal brain

Molecular Endocrinology

Volumn 29, Issue 5, 2015, Pages 658-666

  Peffer, Melanie E ^a   Zhang, Janie Y ^a   Umfrey, Leah ^a   Rudine, Anthony C ^a   Paula Monaghan, A ^b   DeFranco, Donald B ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 43; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE;

ARTICLE; BRAIN DEVELOPMENT; CELL COMMUNICATION; CELL PROLIFERATION; CORTICOSTEROID THERAPY; FETUS DEVELOPMENT; GAP JUNCTION; GESTATIONAL AGE; HUMAN; HYDROCORTISONE BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; MATERNAL STRESS; NEURAL STEM CELL; NEUROLOGICAL COMPLICATION; NONHUMAN; PREGNANT WOMAN; PREMATURITY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STEM CELL CULTURE; ANIMAL; BRAIN; CHEMICALLY INDUCED; DRUG EFFECTS; EMBRYOLOGY; FEMALE; PREGNANCY; PREMATURE BIRTH;

ANIMALIA;

ANIMALS; BRAIN; FEMALE; FETAL DEVELOPMENT; GLUCOCORTICOIDS; HUMANS; PREGNANCY; PREMATURE BIRTH; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84930512978     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2015-1042     Document Type: Article

References (111)

1. Fowden AL, Li J, Forhead AJ. Glucocorticoids and the preparation for life after birth: are there long-term consequences of the life insurance? Proc Nutr Soc. 1998;57:113–122.
2. Crone RK, Davies P, Liggins GC, Reid L. The effects of hypophysectomy, thyroidectomy, and postoperative infusion of cortisol or adrenocorticotrophin on the structure of the ovine fetal lung. J Dev Physiol. 1983;5:281–288.
3. Schellenberg JC, Liggins GC. Elastin and collagen in the fetal sheep lung. I. Ontogenesis. Pediatr Res. 1987;22:335–338.
4. Warburton D, Parton L, Buckley S, Cosico L, Enns G, Saluna T. Combined effects of corticosteroid, thyroid hormones, and -agonist on surfactant, pulmonary mechanics, and -receptor binding in fetal lamb lung. Pediatr Res. 1988;24:166–170.
5. Kitterman JA, Liggins GC, Campos GA, et al. Prepartum maturation of the lung in fetal sheep: relation to cortisol. J Appl Physiol Respir Environ Exerc Physiol. 1981;51:384–390.
6. Ingbar DH, Duvick S, Savick SK, et al. Developmental changes of fetal rat lung Na-K-ATPase after maternal treatment with dexamethasone. Am J Physiol. 1997;272:L665–L672.
7. Wallace MJ, Hooper SB, Harding R. Effects of elevated fetal cortisol concentrations on the volume, secretion, and reabsorption of lung liquid. Am J Physiol. 1995;269:R881–R887.
8. Liggins GC. The role of cortisol in preparing the fetus for birth. Reprod Fertil Dev. 1994;6:141–150.
9. Jones CT, Rolph TP. Metabolism during fetal life: a functional assessment of metabolic development. Physiol Rev. 1985;65:357– 430.
10. Fowden AL, Mijovic J, Silver M. The effects of cortisol on hepatic and renal gluconeogenic enzyme activities in the sheep fetus during late gestation. J Endocrinol. 1993;137:213–222.
11. Wu SY, Klein AH, Chopra IJ, Fisher DA. Alterations in tissue thyroxine-5-monodeiodinating activity in perinatal period. Endocrinology. 1978;103:235–239.
12. Jeffray TM, Berdusco ET, Wallace M, Fowden A, Challis JR. Effects of incremental cortisol and adrenalectomy on plasma corticosteroid binding capacity in fetal sheep. Can J Physiol Pharmacol. 1995;73:1568–1573.
13. Trahair JF, Perry RA, Silver M, Robinson PM. Studies on the maturation of the small intestine in the fetal sheep. II. The effects of exogenous cortisol. Q J Exp Physiol. 1987;72:71–79.
14. Sangild PT, Hilsted L, Nexo E, Fowden AL, Silver M. Secretion of acid, gastrin, and cobalamin-binding proteins by the fetal pig stomach: developmental regulation by cortisol. Exp Physiol. 1994;79:135–146.
15. Sangild PT, Sjostrom H, Noren O, Fowden AL, Silver M. The prenatal development and glucocorticoid control of brush-border hydrolases in the pig small intestine. Pediatr Res. 1995;37:207– 212.
16. Sangild PT, Westrom BR, Fowden AL, Silver M. Developmental regulation of the porcine exocrine pancreas by glucocorticoids. J Pediatr Gastroenterol Nutr. 1994;19:204–212.
17. Sangild PT, Westrom BR, Silver M, Fowden AL. Maturational effects of cortisol on the exocrine abomasum and pancreas in fetal sheep. Reprod Fertil Dev. 1995;7:655–658.
18. Sangild T, Silver M, Fowden AL, Turvey A, Foltmann B. Adrenocortical stimulation of stomach development in the prenatal pig. Biol Neonate. 1994;65:378–389.
19. Stonestreet BS, Hansen NB, Laptook AR, Oh W. Glucocorticoid accelerates renal functional maturation in fetal lambs. Early Hum Dev. 1983;8:331–341.
20. Slotkin TA, Seidler FJ, Kavlock RJ, Gray JA. Fetal dexamethasone exposure accelerates development of renal function: relationship to dose, cell differentiation and growth inhibition. J Dev Physiol. 1992;17:55–61.
21. Towstoless MK, McDougall JG, Wintour EM. Gestational changes in renal responsiveness to cortisol in the ovine fetus. Pediatr Res. 1989;26:6–10.
22. Celsi G, Wang ZM, Akusjarvi G, Aperia A. Sensitive periods for glucocorticoids’ regulation of Na,K()-ATPase mRNA in the developing lung and kidney. Pediatr Res. 1993;33:5–9.
23. Guillery EN, Karniski LP, Mathews MS, et al. Role of glucocorticoids in the maturation of renal cortical Na/H exchanger activity during fetal life in sheep. Am J Physiol. 1995;268:F710– F717.
24. Lim GB, Dodic M, Earnest L, Jeyaseelan K, Wintour EM. Regulation of erythropoietin gene expression in fetal sheep by glucocorticoids. Endocrinology. 1996;137:1658–1663.
25. Wood CE, Cheung CY, Brace RA. Fetal heart rate, arterial pressure, and blood volume responses to cortisol infusion. Am J Physiol. 1987;253:R904–R909.
26. Wood CE, Keil LC, Rudolph AM. Physiological inhibition of ovine fetal plasma renin activity by cortisol. Endocrinology. 1984; 115:1792–1796.
27. Carbone GM, Sheikh AU, Zehnder T, Rose JC. Effect of chronic infusion of cortisol on renin gene expression and renin response to hemorrhage in fetal lambs. Pediatr Res. 1995;37:316–320.
28. Segar JL, Bedell K, Page WV, Mazursky JE, Nuyt AM, Robillard JE. Effect of cortisol on gene expression of the renin-angiotensin system in fetal sheep. Pediatr Res. 1995;37:741–746.
29. Murphy BE. Human fetal serum cortisol levels related to gestational age: evidence of a midgestational fall and a steep late gestational rise, independent of sex or mode of delivery. Am J Obstet Gynecol. 1982;144:276–282.
30. Liggins GC. Premature delivery of foetal lambs infused with glucocorticoids. J Endocrinol. 1969;45:515–523.
31. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972;50:515–525.
32. Crowley PA. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol. 1995; 173:322–335.
33. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006:CD004454.
34. Blanford AT, Murphy BE. In vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta. Am J Obstet Gynecol. 1977;127:264–267.
35. Levitz M, Jansen V, Dancis J. The transfer and metabolism of corticosteroids in the perfused human placenta. Am J Obstet Gynecol. 1978;132:363–366.
36. Buttgereit F, Brand MD, Burmester GR. Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy. Biochem Pharmacol. 1999;58: 363–368.
37. Wapner R, Jobe AH. Controversy: antenatal steroids. Clin Perinatol. 2011;38:529–545.
38. Merrill JD, Ballard RA. Clinical use of antenatal corticosteroids: benefits and risks. Pediatr Rev. 2000;1:E91–E98.
39. Ballard PL, Granberg P, Ballard RA. Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome. J Clin Invest. 1975;56: 1548–1554.
40. Ervin MG, Padbury JF, Polk DH, Ikegami M, Berry LM, Jobe AH. Antenatal glucocorticoids alter premature newborn lamb neuroendocrine and endocrine responses to hypoxia. Am J Physiol Regul Integr Comp Physiol. 2000;279:R830–R838.
41. Smith LM, Ervin MG, Wada N, Ikegami M, Polk DH, Jobe AH. Antenatal glucocorticoids alter postnatal preterm lamb renal and cardiovascular responses to intravascular volume expansion. Pediatr Res. 2000;47:622–627.
42. Wapner RJ, Sorokin Y, Mele L, et al. Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med. 2007;357: 1190–1198.
43. Murphy KE, Hannah ME, Willan AR, et al. Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. Lancet. 2008;372:2143–2151.
44. Crowther CA, McKinlay CJ, Middleton P, Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst Rev. 2011;CD003935.
45. Hashimoto LN, Hornung RW, Lindsell CJ, Brewer DE, Donovan EF. Effects of antenatal glucocorticoids on outcomes of very low birth weight multifetal gestations. Am J Obstet Gynecol. 2002; 187:804–810.
46. Gyamfi C, Mele L, Wapner RJ, et al. The effect of plurality and obesity on betamethasone concentrations in women at risk for preterm delivery. Am J Obstet Gynecol. 2010;203:219.e1– 219.e5.
47. Della Torre M, Hibbard JU, Jeong H, Fischer JH. Betamethasone in pregnancy: influence of maternal body weight and multiple gestation on pharmacokinetics. Am J Obstet Gynecol. 2010;203: 254.e1–254.e12.
48. Shankaran S, Lin A, Maller-Kesselman J, et al. Maternal race, demography, and health care disparities impact risk for intraventricular hemorrhage in preterm neonates. J Pediatr. 2014;164: 1005–1011.e3.
49. Cuestas E, Bas J, Pautasso J. Sex differences in intraventricular hemorrhage rates among very low birth weight newborns. Gend Med. 2009;6:376–382.
50. Brownfoot FC, Crowther CA, Middleton P. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2008;CD006764.
51. Feldman DM, Carbone J, Belden L, Borgida AF, Herson V. Betamethasone vs dexamethasone for the prevention of morbidity in very-low-birthweight neonates. Am J Obstet Gynecol. 2007;197: 284.e1–284.e4.
52. Jobe AH, Soll RF. Choice and dose of corticosteroid for antenatal treatments. Am J Obstet Gynecol. 2004;190:878–881.
53. Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet. 2005;365:2125–2136.
54. Hirvikoski T, Nordenstrom A, Wedell A, Ritzen M, Lajic S. Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: the Swedish experience and standpoint. J Clin Endocrinol Metab. 2012;97:1881–1883.
55. Miller WL. Dexamethasone treatment of congenital adrenal hyperplasia in utero: an experimental therapy of unproven safety. J Urol. 1999;162:537–240.
56. Seckl JR. Prenatal glucocorticoids and long-term programming. Eur J Endocrinol. 2004;151(suppl 3):U49–U62.
57. de Vries A, Holmes MC, Heijnis A, et al. Prenatal dexamethasone exposure induces changes in nonhuman primate offspring cardiometabolic and hypothalamic-pituitary-adrenal axis function. J Clin Invest. 2007;117:1058–1067.
58. Hirvikoski T, Lindholm T, Lajic S, Nordenstrom A. Gender role behaviour in prenatally dexamethasone-treated children at risk for congenital adrenal hyperplasia—a pilot study. Acta Paediatr. 2011;100:e112–e119.
59. Hirvikoski T, Nordenstrom A, Lindholm T, Lindblad F, Ritzen EM, Lajic S. Long-term follow-up of prenatally treated children at risk for congenital adrenal hyperplasia: does dexamethasone cause behavioural problems? Eur J Endocrinol. 2008;159:309–316.
60. Hirvikoski T, Nordenstrom A, Lindholm T, et al. Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone. J Clin Endocrinol Metab. 2007; 92:542–548.
61. Lajic S, Wedell A, Bui TH, Ritzen EM, Holst M. Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1998;83:3872–3880.
62. Speiser PW, Azziz R, Baskin LS, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010; 95:4133–4160.
63. Davis EP, Sandman CA, Buss C, Wing DA, Head K. Fetal glucocorticoid exposure is associated with preadolescent brain development. Biol Psychiatry. 2013;74:647–655.
64. Damsted SK, Born AP, Paulson OB, Uldall P. Exogenous glucocorticoids and adverse cerebral effects in children. Eur J Paediatr Neurol. 2011;15:465–477.
65. Coe CL, Lubach GR. Developmental consequences of antenatal dexamethasone treatment in nonhuman primates. Neurosci Biobehav Rev. 2005;29:227–235.
66. Uno H, Lohmiller L, Thieme C, et al. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Brain Res Dev Brain Res. 1990;53:157–167.
67. Hauser J, Dettling-Artho A, Pilloud S, et al. Effects of prenatal dexamethasone treatment on postnatal physical, endocrine, and social development in the common marmoset monkey. Endocrinology. 2007;148:1813–1822.
68. Rodriguez JS, Zurcher NR, Keenan KE, Bartlett TQ, Nathanielsz PW, Nijland MJ. Prenatal betamethasone exposure has sex specific effects in reversal learning and attention in juvenile baboons. Am J Obstet Gynecol. 2011;204:545.e1–545.e10.
69. Hauser J, Feldon J, Pryce CR. Direct and dam-mediated effects of prenatal dexamethasone on emotionality, cognition and HPA axis in adult Wistar rats. Horm Behav. 2009;56:364–375.
70. Noorlander CW, Visser GH, Ramakers GM, Nikkels PG, de Graan PN. Prenatal corticosteroid exposure affects hippocampal plasticity and reduces lifespan. Dev Neurobiol. 2008;68:237–246.
71. Moisiadis VG, Matthews SG. Glucocorticoids and fetal programming, part 1: outcomes. Nat Rev Endocrinol. 2014;10:391–402.
72. Modi N, Lewis H, Al-Naqeeb N, Ajayi-Obe M, Dore CJ, Rutherford M. The effects of repeated antenatal glucocorticoid therapy on the developing brain. Pediatr Res. 2001;50:581–585.
73. Spinillo A, Viazzo F, Colleoni R, Chiara A, Maria Cerbo R, Fazzi E. Two-year infant neurodevelopmental outcome after single or multiple antenatal courses of corticosteroids to prevent complications of prematurity. Am J Obstet Gynecol. 2004;191:217–224.
74. Crowther CA, Doyle LW, Haslam RR, et al. Outcomes at 2 years of age after repeat doses of antenatal corticosteroids. N Engl J Med. 2007;357:1179–1189.
75. MacArthur BA, Howie RN, Dezoete JA, Elkins J. School progress and cognitive development of 6-year-old children whose mothers were treated antenatally with betamethasone. Pediatrics. 1982;70: 99–105.
76. French NP, Hagan R, Evans SF, Mullan A, Newnham JP. Repeated antenatal corticosteroids: effects on cerebral palsy and childhood behavior. Am J Obstet Gynecol. 2004;190:588–595.
77. Bustamante C, Valencia M, Torres C, et al. Effects of a single course of prenatal betamethasone on dendritic development in dentate gyrus granular neurons and on spatial memory in rat offspring. Neuropediatrics. 2014;45:354–361.
78. Waffarn, Davis EP. Effects of antenatal corticosteroids on the hypothalamic-pituitary-adrenocortical axis of the fetus and newborn: experimental findings and clinical considerations. Am J Obstet Gynecol. 2012;207:446–454.
79. Alexander N, Rosenlocher F, Stalder T, et al. Impact of antenatal synthetic glucocorticoid exposure on endocrine stress reactivity in term-born children. J Clin Endocrinol Metab. 2012;97:3538– 3544.
80. Charil A, Laplante DP, Vaillancourt C, King S. Prenatal stress and brain development. Brain Res Rev. 2010;65:56–79.
81. Mueller BR, Bale TL. Sex-specific programming of offspring emotionality after stress early in pregnancy. J Neurosci. 2008;28: 9055–9065.
82. Moisiadis VG, Matthews SG. Glucocorticoids and fetal programming part 2: Mechanisms. Nat Rev Endocrinol. 2014;10:403– 411.
83. Desvergne B, Heligon C. Steroid hormone pulsing drives cyclic gene expression. Nat Cell Biol. 2009;11:1051–1053.
84. Peffer ME, Chandran UR, Luthra S, et al. Caveolin-1 regulates genomic action of the glucocorticoid receptor in neural stem cells. Mol Cell Biol. 2014;34(14):2611–2623.
85. Samarasinghe RA, Di Maio R, Volonte D, et al. Nongenomic glucocorticoid receptor action regulates gap junction intercellular communication and neural progenitor cell proliferation. Proc Natl Acad Sci USA. 2011;108:16657–16662.
86. Sundberg M, Savola S, Hienola A, Korhonen L, Lindholm D. Glucocorticoid hormones decrease proliferation of embryonic neural stem cells through ubiquitin-mediated degradation of cyclin D1. J Neurosci. 2006;26:5402–5410.
87. Sippel M, Rajala R, Korhonen L, et al. Dexamethasone regulates expression of BRUCE/Apollon and the proliferation of neural progenitor cells. FEBS Lett. 2009;583:2213–2217.
88. Li SY, Wang P, Tang Y, Huang L, Wu YF, Shen HY. Analysis of methylprednisolone-induced inhibition on the proliferation of neural progenitor cells in vitro by gene expression profiling. Neurosci Lett. 2012;526:154–159.
89. Yu S, Patchev AV, Wu Y, Lu J, et al. Depletion of the neural precursor cell pool by glucocorticoids. Ann Neurol. 2010;67:21– 30.
90. Ichinohashi Y, Sato Y, Saito A, et al. Dexamethasone administration to the neonatal rat results in neurological dysfunction at the juvenile stage even at low doses. Early Hum Dev. 2013;89:283– 288.
91. Alonso G. Prolonged corticosterone treatment of adult rats inhibits the proliferation of oligodendrocyte progenitors present throughout white and gray matter regions of the brain. Glia. 2000; 31:219–231.
92. Kim JB, Ju JY, Kim JH, et al. Dexamethasone inhibits proliferation of adult hippocampal neurogenesis in vivo and in vitro. Brain Res 2004;1027:1–10.
93. Schroter A, Lustenberger RM, Obermair FJ, Thallmair M. Highdose corticosteroids after spinal cord injury reduce neural progenitor cell proliferation. Neuroscience. 2009;161:753–763.
94. Bose R, Moors M, Tofighi R, Cascante A, Hermanson O, Ceccatelli S. Glucocorticoids induce long-lasting effects in neural stem cells resulting in senescence-related alterations. Cell Death Dis. 2010;1:e92.
95. Moors M, Bose R, Johansson-Haque K, Edoff K, Okret S, Ceccatelli S. Dickkopf 1 mediates glucocorticoid-induced changes in human neural progenitor cell proliferation and differentiation. Toxicol Sci. 2012;125:488–495.
96. Huang WL, Harper CG, Evans SF, Newnham JP, Dunlop SA. Repeated prenatal corticosteroid administration delays myelination of the corpus callosum in fetal sheep. Int J Dev Neurosci. 2001;19:415–425.
97. Kim JW, Kim YJ, Chang YP. Administration of dexamethasone to neonatal rats induces hypomyelination and changes in the morphology of oligodendrocyte precursors. Comp Med. 2013; 63:48–54.
98. Jenkins SI, Pickard MR, Khong M, et al. Identifying the cellular targets of drug action in the central nervous system following corticosteroid therapy. ACS Chem Neurosci. 2014;5:51–63.
99. Zia MT, Vinukonda G, Vose LR, et al. Postnatal glucocorticoidinduced hypomyelination, gliosis, and neurologic deficits are dosedependent, preparation-specific, and reversible. Exp Neurol. 2015;263:200–213.
100. Ninomiya E, Hattori T, Toyoda M, Umezawa A, Hamazaki T, Shintaku H. Glucocorticoids promote neural progenitor cell proliferation derived from human induced pluripotent stem cells. Springerplus. 2014;3:527.
101. Tsiarli MA, Paula Monaghan A, DeFranco DB. Differential subcellular localization of the glucocorticoid receptor in distinct neural stem and progenitor populations of the mouse telencephalon in vivo. Brain Res. 2013;1523:10–27.
102. Qian X, Shen Q, Goderie SK, et al. Timing of CNS cell generation: a programmed sequence of neuron and glial cell production from isolated murine cortical stem cells. Neuron. 2000;28:69–80.
103. Shen Q, Wang Y, Dimos JT, Fasano CA, et al. The timing of cortical neurogenesis is encoded within lineages of individual progenitor cells. Nat Neurosci. 2006;9:743–751.
104. Schmitt A, Malchow B, Hasan A, Falkai P. The impact of environmental factors in severe psychiatric disorders. Front Neurosci. 2014;8:19.
105. Malmersjo S, Rebellato P, Smedler E, et al. Neural progenitors organize in small-world networks to promote cell proliferation. Proc Natl Acad Sci USA. 2013;110:E1524–E1532.
106. Hammes SR, Levin ER. Minireview: recent advances in extranuclear steroid receptor actions. Endocrinology. 2011;152:4489– 4495.
107. Chen W, Dang T, Blind RD, et al. Glucocorticoid receptor phosphorylation differentially affects target gene expression. Mol Endocrinol. 2008;22:1754–1766.
108. Anacker C, Cattaneo A, Musaelyan K, et al. Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis. Proc Natl Acad Sci USA. 2013;110: 8708–8713.
109. Mohamed MA, Aly H. Male gender is associated with intraventricular hemorrhage. Pediatrics. 2010;125:e333–e339.
110. Carbone DL, Zuloaga DG, Hiroi R, Foradori CD, Legare ME, Handa RJ. Prenatal dexamethasone exposure potentiates diet-induced hepatosteatosis and decreases plasma IGF-I in a sex-specific fashion. Endocrinology. 2012;153:295–306.
111. Ballabh P. Intraventricular hemorrhage in premature infants: mechanism of disease. Pediatr Res. 2010;67:1–8.